117 related articles for article (PubMed ID: 21092650)
1. [Statin reduced triglyceride level via activating peroxisome proliferator activated receptor α and upregulating apolipoprotein A5 in hypertriglyceridemic rats].
HUANG XS; ZHAO SP; BAI L; ZHANG Q; HU M; ZHAO W
Zhonghua Xin Xue Guan Bing Za Zhi; 2010 Sep; 38(9):809-13. PubMed ID: 21092650
[TBL] [Abstract][Full Text] [Related]
2. Atorvastatin and fenofibrate increase apolipoprotein AV and decrease triglycerides by up-regulating peroxisome proliferator-activated receptor-alpha.
Huang XS; Zhao SP; Bai L; Hu M; Zhao W; Zhang Q
Br J Pharmacol; 2009 Oct; 158(3):706-12. PubMed ID: 19694729
[TBL] [Abstract][Full Text] [Related]
3. Xuezhikang contributes to greater triglyceride reduction than simvastatin in hypertriglyceridemia rats by up-regulating apolipoprotein A5 via the PPARα signaling pathway.
Zhao SP; Li R; Dai W; Yu BL; Chen LZ; Huang XS
PLoS One; 2017; 12(9):e0184949. PubMed ID: 28934253
[TBL] [Abstract][Full Text] [Related]
4. Atorvastatin treatment induced peroxisome proliferator-activated receptor alpha expression and decreased plasma nonesterified fatty acids and liver triglyceride in fructose-fed rats.
Roglans N; Sanguino E; Peris C; Alegret M; Vázquez M; Adzet T; Díaz C; Hernández G; Laguna JC; Sánchez RM
J Pharmacol Exp Ther; 2002 Jul; 302(1):232-9. PubMed ID: 12065722
[TBL] [Abstract][Full Text] [Related]
5. Apolipoprotein A5 and hypertriglyceridemia in Prague hypertriglyceridemic rats.
Kadlecová M; Hojná S; Bohuslavová R; Hubácek JA; Zicha J; Kunes J
Physiol Res; 2006; 55(4):373-379. PubMed ID: 16238453
[TBL] [Abstract][Full Text] [Related]
6. Atorvastatin reverses age-related reduction in rat hepatic PPARalpha and HNF-4.
Sanguino E; Roglans N; Alegret M; Sánchez RM; Vázquez-Carrera M; Laguna JC
Br J Pharmacol; 2005 Aug; 145(7):853-61. PubMed ID: 15912134
[TBL] [Abstract][Full Text] [Related]
7. Up-regulation of hepatic low-density lipoprotein receptor-related protein 1: a possible novel mechanism of antiatherogenic activity of hydroxymethylglutaryl-coenzyme A reductase inhibitor Atorvastatin and hepatic LRP1 expression.
Moon JH; Kang SB; Park JS; Lee BW; Kang ES; Ahn CW; Lee HC; Cha BS
Metabolism; 2011 Jul; 60(7):930-40. PubMed ID: 20951395
[TBL] [Abstract][Full Text] [Related]
8. The influence of statin-fibrate combination therapy on lipids profile and apolipoprotein A5 in patients with acute coronary syndrome.
Li XP; Gong HR; Huang XS; Huang WY; Zhao SP
Lipids Health Dis; 2013 Sep; 12():133. PubMed ID: 24016248
[TBL] [Abstract][Full Text] [Related]
9. Metformin ameliorates obesity-associated hypertriglyceridemia in mice partly through the apolipoprotein A5 pathway.
Li R; Chen LZ; Zhao W; Zhao SP; Huang XS
Biochem Biophys Res Commun; 2016 Sep; 478(3):1173-8. PubMed ID: 27544029
[TBL] [Abstract][Full Text] [Related]
10. Decreased apolipoprotein A5 is implicated in insulin resistance-related hypertriglyceridemia in obesity.
Huang XS; Zhao SP; Hu M; Bai L; Zhang Q; Zhao W
Atherosclerosis; 2010 Jun; 210(2):563-8. PubMed ID: 20047745
[TBL] [Abstract][Full Text] [Related]
11. Differential regulation of the human versus the mouse apolipoprotein AV gene by PPARalpha. Implications for the study of pharmaceutical modifiers of hypertriglyceridemia in mice.
Prieur X; Lesnik P; Moreau M; Rodríguez JC; Doucet C; Chapman MJ; Huby T
Biochim Biophys Acta; 2009 Aug; 1791(8):764-71. PubMed ID: 19362162
[TBL] [Abstract][Full Text] [Related]
12. Omega-3 fatty acids and atorvastatin affect connexin 43 expression in the aorta of hereditary hypertriglyceridemic rats.
Dlugosová K; Weismann P; Bernátová I; Sotníková R; Slezák J; Okruhlicová L
Can J Physiol Pharmacol; 2009 Dec; 87(12):1074-82. PubMed ID: 20029544
[TBL] [Abstract][Full Text] [Related]
13. Regulation mechanism of ABCA1 expression by statins in hepatocytes.
Kobayashi M; Gouda K; Chisaki I; Ochiai M; Itagaki S; Iseki K
Eur J Pharmacol; 2011 Jul; 662(1-3):9-14. PubMed ID: 21554872
[TBL] [Abstract][Full Text] [Related]
14. The role of apolipoprotein A5 in non-alcoholic fatty liver disease.
Ress C; Moschen AR; Sausgruber N; Tschoner A; Graziadei I; Weiss H; Schgoer W; Ebenbichler CF; Konrad RJ; Patsch JR; Tilg H; Kaser S
Gut; 2011 Jul; 60(7):985-91. PubMed ID: 21339203
[TBL] [Abstract][Full Text] [Related]
15. Apolipoprotein AV does not contribute to hypertriglyceridaemia or triglyceride lowering by dietary fish oil and rosiglitazone in obese Zucker rats.
Dorfmeister B; Brandlhofer S; Schaap FG; Hermann M; Fürnsinn C; Hagerty BP; Stangl H; Patsch W; Strobl W
Diabetologia; 2006 Jun; 49(6):1324-32. PubMed ID: 16570166
[TBL] [Abstract][Full Text] [Related]
16. Plasma apolipoprotein A5 and triglycerides in type 2 diabetes.
Dallinga-Thie GM; van Tol A; Hattori H; van Vark-van der Zee LC; Jansen H; Sijbrands EJ;
Diabetologia; 2006 Jul; 49(7):1505-11. PubMed ID: 16752169
[TBL] [Abstract][Full Text] [Related]
17. Omega-3 fatty acids and atorvastatin suppress ventricular fibrillation inducibility in hypertriglyceridemic rat hearts: implication of intracellular coupling protein, connexin-43.
Bacova B; Radosinska J; Knezl V; Kolenova L; Weismann P; Navarova J; Barancik M; Mitasikova M; Tribulova N
J Physiol Pharmacol; 2010 Dec; 61(6):717-23. PubMed ID: 21224503
[TBL] [Abstract][Full Text] [Related]
18. Reduction in hepatic non-esterified fatty acid concentration after long-term treatment with atorvastatin lowers hepatic triglyceride synthesis and its secretion in sucrose-fed rats.
Funatsu T; Goto M; Kakuta H; Suzuki M; Ida M; Nishijima S; Tanaka H; Yasuda S; Miyata K
Biochim Biophys Acta; 2002 Feb; 1580(2-3):161-70. PubMed ID: 11880241
[TBL] [Abstract][Full Text] [Related]
19. APOA5 gene expression in the human intestinal tissue and its response to in vitro exposure to fatty acid and fibrate.
Guardiola M; Alvaro A; Vallvé JC; Rosales R; Solà R; Girona J; Serra N; Duran P; Esteve E; Masana L; Ribalta J
Nutr Metab Cardiovasc Dis; 2012 Sep; 22(9):756-62. PubMed ID: 21489765
[TBL] [Abstract][Full Text] [Related]
20. Inflammatory stress induces statin resistance by disrupting 3-hydroxy-3-methylglutaryl-CoA reductase feedback regulation.
Chen Y; Ku H; Zhao L; Wheeler DC; Li LC; Li Q; Varghese Z; Moorhead JF; Powis SH; Huang A; Ruan XZ
Arterioscler Thromb Vasc Biol; 2014 Feb; 34(2):365-76. PubMed ID: 24233489
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
